Long-term potentiation (LTP) in the hippocampus is a good model of synaptic plasticity and is widely believed to correlate with learning and memory (1). LTP is triggered by activation of postsynaptic N-methyl-D-aspartate (NMDA) receptors, and its maintenance requires both presynaptic and postsynaptic alternations (2), indicating that a retrograde messenger must be sent from the postsynaptic neuron to the presynaptic terminals. Nitric oxide (NO) is a good candidate for such a messenger (3), supported by many findings that inhibitors of NO syn thase block the induction of hippocampal LTP (4 8) and impair some types of learning (9-11). NO, formed from L-arginine by NO synthase, is a short-lived free radical gas that can activate guanylyl cyclase. In 1993, Verma et al. (12) proposed that carbon monoxide (CO) is also a retrograde messenger that activates guanylyl cyclase. CO is produced by heme oxygenase through the metabolism of heme. Recent evidence suggests that CO is involved in the generation of hippocampal LTP (13 15). However, the association of CO and learning has not yet been fully elucidated. Therefore, we investigated the effects of Zn protoporphyrin IX, an inhibitor of heme oxygenase, on passive avoidance learning (step through test, step down test) and spatial learning (water maze test) in mice. As a comparison, we also tested the effects of N-w-nitro-L arginine, an inhibitor of NO synthase.
MATERIALS AND METHODS

Animals and surgery
Male ddY mice, 7 to 8-weeks-old, were purchased from Japan SLC (Hamamatsu).
Each mouse was anesthetized with sodium pentobarbital (65 mg/kg, i.p.) and fixed in a stereotaxic instrument. A stainless steel cylindrical cannula (0.6 mm o.d., 0.35 mm i.d., 5.0-mm long) was implanted so that the tip of the cannula was placed in the left lateral ventricle (1.3 mm lateral to the midline, 0.3 mm posterior to the bregma, 2.0 mm ventral to the dura). The implanted cannula was fixed to the skull with a screw and dental acrylic cement and plugged with a stainless steel wire pin. The cannula served as a guide for i.c.v. injection of drug solutions. The operated mice were allowed 7 10 days to recover from the surgery. All mice were housed individually under conditions of controlled temperature and humidity (22C, 55%) with ad libitum access to food and water. Body weights were monitored every day. The mice in the intact group were not subject ed to the operation but were kept under the same condi tions.
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Drugs
The drugs used in this study were Zn-protoporphyrin IX (ZnPP; Aldrich Chemical Co., Milwaukee, WI, USA) and N-w-nitro-L-arginine (L-NOArg; Sigma Chemical Co., St. Louis, MO, USA). ZnPP was diluted to the desired concentrations with dimethyl sulfoxide (DMSO), and 0.5 ,i1 of the drug solution was injected into the left lateral ventricle. L-NOArg was diluted with saline and a volume of 5.0 it was injected. A stainless steel tube (0.35 mm o.d., 0.15 mm i.d.) was used to inject the drugs. The injection tube, the tip of which protruded 0.5 mm below the tip of the guide cannula, was connected to a Hamilton syringe via a polyethylene tube. The injection time was about 30 sec for 0.5 t1 and 90 sec for 5.0 p1.
Passive avoidance learning
Step through test: The apparatus (Model PA-Ml; O'hara Co., Ltd., Tokyo) consisted of a lit compartment and a dark compartment with a electrifiable grid floor. The two compartments were separated by a black parti tion with a rectangular doorway in the center. For the learning trial, a mouse was placed in the lit compartment 30-60 min after the i.c.v. injection of either drug or vehi cle. The latency before entering the dark compartment was recorded. When the mouse entered into the dark compartment and crossed an infrared beam placed 5 cm from the border, it received a 36 V AC footshock until it returned to the lit compartment. The mouse that received the shock was removed immediately so that it did not reenter the dark compartment. The testing trial was per formed 24 hr later. The mouse was put into the lit com partment again. If the mouse did not enter the dark com partment within 300 sec, the test was terminated and a latency of 300 sec was recorded.
Step down test: The apparatus was a rectangular box (10 x 15 x 40 cm high) with an electrifiable grid floor and a rubber columnar platform (diameter: 3.5 cm, height: 4.0 cm) in one corner. For the learning trial, a mouse was placed on the platform 30-60 min after the i.c.v. injection of either drug or vehicle. When the mouse stepped onto the floor and received a 60 V AC footshock, it was countered as an error. The mouse was exposed to this condition for 10 min. The number of errors in the latter half of the 10 min was counted. The mouse was again placed on the platform 24 hr later, and the number of er rors was counted for 3 min as the testing trial. The step down test was performed soon after the step through test.
Motor activity
Just before the passive avoidance tests, a mouse was put into a round tilting-type apparatus (Model GT-8450; O'hara; diameter: 18 cm, height: 18 cm), and the amount of motor activity was measured over a 30-min period.
Spatial learning
Morris-type water maze test: A circular blue pool (di ameter: 74 cm, depth: 32 cm) was filled with water so that water depth was 27 cm. The temperature of the water was maintained at 18±1'C. The pool was surrounded by various prominent cues that remained throughout the ex periment. Regions (1 -4) and start positions (I and II) of the pool were decided as described in Fig. 4c . The move ment of each mouse in the pool was recorded with a video camera, and a computerized tracking and analyzing sys tem was used. On the day before the start of experiment, a mouse was placed in the pool and allowed to swim freely for 90 sec without a platform. On day 0, a circular black platform (visible platform, diameter: 10 cm) was placed in region 1, and its top surface was 0.5 cm above the water level. The mouse was placed into the water fac ing the wall at start position I. The mouse was allowed for a maximum of 90 sec to find the platform to escape from the water. If the mouse could not escape within 90 sec, it was picked up and placed on the platform. In any case, it was allowed to stay there for exactly 30 sec. On day 1 to day 6, a circular transparent platform (invisible platform, diameter: 10 cm) was placed in region 1, and its top sur face was 0.5 cm below the water level. Two trials were conducted in a day at an interval of 5 min. As the first trial of the day, the start position of I or II was randomly chosen; and for the second trial, the other start position was employed. Other procedures were the same as day 0. On the final day (day 7), each mouse was placed in the pool at start position I without the platform, and its swimming pattern was recorded for 90 sec. On each day (day 0-day 7), the mice other than the intact group received an i.c.v. injection of vehicle or drug solution 30-60 min before the trials.
Statistics
The latencies in the step through test were analyzed by Dunnett's test. For all the other data, ANOVA followed by Duncan's multiple range test was employed.
RESULTS
Body weight
The operation decreased the body weights of almost all the mice, but by 7 to 10 days after the surgery, their body weights had recovered. A single injection of any drug did not affect the body weight measured on the next day. The mice used for the water maze test received either vehicle or the drugs for eight days, and we weighed all the mice every day. However, there were no significant differences among the groups, suggesting that the daily i.c.v. injec tion of ZnPP or L-NOArg did not affect the increasing rate of body weight (data not shown).
Motor activity
During the passive avoidance tests, motor acivity was measured with a tilting type ambulometor for 30 min just before the learning and testing trials. Neither ZnPP nor L-NOArg influenced the motor activity (Fig. 1) . Fig. 1 . Effects of ZnPP (a) and L-NOArg (b) on motor activity. Motor activities were measured for 30 min before the learning trial (immediately after the drug injection, FI) and before the testing trial without drug injection (®). Each value represents the mean ±S.E.M. from 6 to 11 animals. 
Passive avoidance learning (step through test and step down test)
To investigate the effects of drugs on the acquisition of passive avoidance learning, we administered drugs 30 to 60 min before the learning trial.
Step through test: Almost all the mice in any group learned the test very well and did not enter the dark com partment within 300 sec on the learning trial, although all the mice entered on the testing trial. Neither ZnPP nor L-NOArg affected the latencies to enter the dark com partment (Figs. 2a and 3a) .
Step down test: The number of errors on the testing trial in the 10 nmol ZnPP-treated group (3.8±0.7, n=6) was higher than that in the intact (1.1 ± 0.5, n = 10) and vehicle-treated groups (1.7±0.2, n=7), but 20 nmol ZnPP had no effect (1.3±0.6, n=6) (Fig. 2b) . We con ducted an additional experiment in which the effects of 10 and 100 nmol ZnPP were tested. However, there was no significant difference among intact-, vehicle and ZnPP treated groups (data not shown). On the other hand, L NOArg tended to increase the number of errors in the testing trial dose-dependently (intact: 0.4+0.3, n=9; vehicle: 0.7±0.2, n=11; 10 nmol L-NOArg: 1.0±0.4, n=10; 40 nmol L-NOArg: 1.4±0.3, n=11), but this effect did not reach statistical significance (Fig. 3b) .
Spatial learning (water maze test)
Free swimming for 90 sec on the day before the start of the experiment was conducted to allow the mice to become accustomed to water. All mice could swim well with the characteristic swimming posture.
In the visible platform task on day 0, there was no sig nificant difference in escape latency among the groups (data not shown), suggesting that no treatment caused gross sensorimotor disturbance.
In the invisible platform task on day 1 to day 6, ZnPP treated groups learned to escape onto the platform as rapidly as the intact and vehicle-treated groups (Fig. 4a) . In contrast, the 40 nmol L-NOArg-treated group learned a little more slowly; especially, on day 4, they took a sig nificantly longer time to escape (54.3 ± 15.0, P < 0.01 vs intact group; P<0.05 vs vehicle-treated group, n=9) than the intact (15.7-L3.2, n=10) and vehicle-treated groups (28.4±6.4, n=11) (Fig. 5a) . A significant effect of 40 nmol L-NOArg was also observed when the total latency of day 1 to day 6 were compared (P < 0.01 vs in tact group) (Fig. 5b) . However, the total latency was not modified by ZnPP (Fig. 4b) .
Memory retention of the platform location was as sessed in the no platform task on day 7. Mice of all groups crossed region 1 of the pool more frequently where the platform had been located, suggesting that they remembered the former location of the platform, but the groups differed with respect to the extent of learning. The number of crossings of region 1 in the 10 nmol ZnPP treated group (5.4 ± 1. 2, n = 7) was slightly less than those of the intact (7.7± 1.2, n=10) and vehicle-treated groups (7.0 ± 1.0, n = 7), but 20 nmol ZnPP had no significant effect (7.8±1.3, n=8) (Fig. 4c) . In addition, no sig nificant difference was observed in the invisible platform task. ZnPP, therefore, appeared to have no significant effect on the water maze test. On the contrary, i.c.v. in jection of L-NOArg decreased the number of crossings of region 1 dose-dependently; and the 40 nmol L-NOArg treated group crossed the four regions almost equally (region 1: 5.1 ±0.7, region 2: 5.0±0.8, region 3: 3.8±0.6, region 4: 4.7±0.7, n=9) (Fig. 5c ), although they escaped to the platform as fast as the mice in the othei groups on the last day of the invisible platform task, day 6. This indicates that the apparent learning level of the 40 nmol L-NOArg-treated group was lower than those of the intact and vehicle-treated groups. down test, 20 nmol ZnPP had no effect; and moreover, we found no significant difference in the additional ex periment. Therefore, it is unlikely that this 10 nmol ZnPP effect was really due to the drug action of ZnPP itself, and we concluded that ZnPP does not affect passive avoidance learning.
The generation of hippocampal LTP in vivo was at tenuated by ZnPP (15) On the other hand, much evidence based on compa rable effects of drugs on LTP and learning supports the relationship between hippocampal LTP and spatial learn ing. For example, the induction of LTP requires the acti vation of NMDA receptors (16), and the NMDA an tagonist D-AP5 impairs spatial learning at a dose com parable to that inhibiting of hippocampal LTP in vivo (17). Moreover, transgenic alterations of the expression of key proteins in the LTP process such as fyn tyrosine kinase (18) also lead to concomitant impairment of LTP and deficit of spatial learning. Similarly, several studies have shown that inhibitors of NO synthase block the induction of hippocampal LTP both in vitro (4-7) and in vivo (8), and they impair certain forms of learning including spatial learning (9, 10). The inhibitors of heme oxygenase also prevent the induction of LTP in the CAI region of hippocampal slices (13, 14) and in the dentate gyrus in vivo (15). Under the hypothesis that hippocam pal LTP and spatial learning share a common underlying mechanism, therefore, ZnPP as well as L-NOArg may impair spatial learning. Heme oxygenase-2, the predominant form of heme oxygenase in the brain, is highly expressed in hippocampal CAI pyramidal cells (12) and the dose of ZnPP used here is assumed to be sufficient to inhibit heme oxygenase fully in the brain (12, 13). Ac tually, we showed that i.c.v. injection of ZnPP attenu ated the induction of LTP (15) under experimental con ditions similar to those employed in the present study. In the present study, however, L-NOArg but not ZnPP impaired spatial learning.
